CO5070621A1 - METHOD FOR INCREASING THE OSEO VOLUME - Google Patents

METHOD FOR INCREASING THE OSEO VOLUME

Info

Publication number
CO5070621A1
CO5070621A1 CO98051809A CO98051809A CO5070621A1 CO 5070621 A1 CO5070621 A1 CO 5070621A1 CO 98051809 A CO98051809 A CO 98051809A CO 98051809 A CO98051809 A CO 98051809A CO 5070621 A1 CO5070621 A1 CO 5070621A1
Authority
CO
Colombia
Prior art keywords
volume
oseo
increasing
subject
medicament
Prior art date
Application number
CO98051809A
Other languages
Spanish (es)
Inventor
James Richard Hartke
Mark Walden Lundy
Mitchell Anthony Delong
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CO5070621A1 publication Critical patent/CO5070621A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se relaciona con un agente que primariamente activa la proteína osteoblástica quinasa C y las vías intracelulares de calcio de un sujeto utilizado en la manufactura de un medicamento para aumentar el volumen óseo del sujeto.The present invention relates to an agent that primarily activates the osteoblastic protein kinase C and the intracellular calcium pathways of a subject used in the manufacture of a medicament to increase the bone volume of the subject.

CO98051809A 1997-09-09 1998-09-09 METHOD FOR INCREASING THE OSEO VOLUME CO5070621A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5821897P 1997-09-09 1997-09-09

Publications (1)

Publication Number Publication Date
CO5070621A1 true CO5070621A1 (en) 2001-08-28

Family

ID=22015432

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98051809A CO5070621A1 (en) 1997-09-09 1998-09-09 METHOD FOR INCREASING THE OSEO VOLUME

Country Status (17)

Country Link
EP (1) EP1035853A1 (en)
JP (1) JP2001515863A (en)
CN (1) CN1269720A (en)
AR (1) AR013478A1 (en)
AU (1) AU9130298A (en)
BR (1) BR9811775A (en)
CA (1) CA2303799A1 (en)
CO (1) CO5070621A1 (en)
HU (1) HUP0003584A3 (en)
ID (1) ID24759A (en)
IL (1) IL134759A0 (en)
NO (1) NO20001172L (en)
PE (1) PE118899A1 (en)
PL (1) PL339297A1 (en)
SK (1) SK3402000A3 (en)
WO (1) WO1999012550A1 (en)
ZA (1) ZA988229B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1159266B1 (en) * 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015767A1 (en) * 1992-02-05 1993-08-19 Merck & Co., Inc. Implant therapy for bone growth stimulation
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS

Also Published As

Publication number Publication date
NO20001172D0 (en) 2000-03-07
NO20001172L (en) 2000-05-08
PL339297A1 (en) 2000-12-04
JP2001515863A (en) 2001-09-25
AU9130298A (en) 1999-03-29
HUP0003584A3 (en) 2002-12-28
ZA988229B (en) 1999-03-09
WO1999012550A1 (en) 1999-03-18
PE118899A1 (en) 2000-02-03
ID24759A (en) 2000-08-03
EP1035853A1 (en) 2000-09-20
CA2303799A1 (en) 1999-03-18
BR9811775A (en) 2000-08-29
SK3402000A3 (en) 2000-12-11
HUP0003584A2 (en) 2001-02-28
AR013478A1 (en) 2000-12-27
CN1269720A (en) 2000-10-11
IL134759A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
MX9306239A (en) PHARMACEUTICAL COMPOSITION FORMING AN IN VIVO LECITHIN GEL FOR THE MAINTAINED RELEASE OF A BIOLOGICALLY ACTIVE COMPOUND AND PROCEDURE FOR THE PREPARATION OF THE SAME.
ES2172670T3 (en) PIRROLPIRIMIDINAS AND PROCEDURES FOR THEIR PREPARATION.
ECSP105739A (en) NEUTRALIZATION ANTIBODIES AGAINST GDF-8
DE69029257D1 (en) ARRANGEMENT FOR RADIATION OF LASER RAYS
ES2183351T3 (en) COMPOSITIONS THAT INCLUDE CONJUGATES OF STABLE ACTIVE HUMAN PROTEIN WITH AN FC CHAIN OF IMMUNOGLOBULINS AND METHODS.
SE8904036L (en) LED PROTES, IN PARTICULAR, FOOT LEADER
ES2173868T3 (en) USE OF RELAXIN FOR THE MANUFACTURE OF A MEDICINAL PRODUCT INTENDED FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
AR013479A1 (en) METHOD TO INCREASE BONE VOLUME USING NON-NATURAL SELECTIVE PROSTANOID F AGONISTS.
ES2083597T3 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PROLONGED COAGULATION TIME.
EE200200565A (en) Combination therapy with vascular adverse effects
DE69814394D1 (en) USE OF LEVOBUPIVACAIN
BR0107628A (en) 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation
DE69943067D1 (en) Use of three-dimensional prostheses containing hyaluronic acid derivatives
ES2168766T3 (en) PHARMACEUTICAL PREPARATION THAT INCLUDES THE PROVIDED VWF.
CO5070621A1 (en) METHOD FOR INCREASING THE OSEO VOLUME
PA8613101A1 (en) AMINO ACIDS WITH AFFINITY FOR PROTEIN ALFA 2 DELTA
AR003001A1 (en) PHARMACEUTICAL COMPOSITION STIMULATING OSTEOGENESIS.
AR023464A1 (en) NEW NOVELS OF THE OX2 PROTEIN OF MAMMER AND RELATED REAGENTS
DE69734349D1 (en) TREATMENT OF BONE DRESS WITH ADRENOMEDULLIN
BR0211323A (en) Combination of active ingredients, use of a combination of active ingredients, and nicotine dependence drug therapy method
ES2151489T3 (en) PROCEDURE AND COMPOSITION FOR THE TREATMENT OF HERPES-RELATED DISORDERS.
AR013498A1 (en) USE OF IFN-ALPHA AND AMANTADINE FOR THE TREATMENT OF CHRONIC HEPATITIS C USE OF IFN-ALPHA
BR0202759A (en) Modified release pharmaceutical composition containing bupropion as active substance
ECSP982800A (en) METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
BR9612549A (en) Method for treating excessive aggression